Opportunity ID: 336481

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-355
Funding Opportunity Title: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.865 — Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 09, 2021
Last Updated Date: Nov 09, 2021
Original Closing Date for Applications: Nov 16, 2024
Current Closing Date for Applications: Nov 16, 2024
Archive Date: Dec 22, 2024
Estimated Total Program Funding:
Award Ceiling: $275,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Public and State controlled institutions of higher education
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
State governments
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
County governments
City or township governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for “high priority” genetic conditions where screening may be possible in the near future. Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a “high priority” condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-355.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Folder 336481 Full Announcement-PAR-21-355 -> PAR-21-355-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00270321 Jan 16, 2022 Jan 24, 2023 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00270050 Jan 16, 2022 Jan 24, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278138 Nov 08, 2022 Nov 16, 2024 View

Package 1

Mandatory forms

336481 RR_SF424_5_0-5.0.pdf

336481 PHS398_CoverPageSupplement_5_0-5.0.pdf

336481 RR_OtherProjectInfo_1_4-1.4.pdf

336481 PerformanceSite_4_0-4.0.pdf

336481 RR_KeyPersonExpanded_4_0-4.0.pdf

336481 PHS398_ResearchPlan_4_0-4.0.pdf

336481 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

336481 RR_Budget_3_0-3.0.pdf

336481 RR_SubawardBudget30_3_0-3.0.pdf

336481 PHS398_ModularBudget_1_2-1.2.pdf

336481 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

336481 RR_SF424_2_0-2.0.pdf

336481 PHS398_CoverPageSupplement_5_0-5.0.pdf

336481 RR_OtherProjectInfo_1_4-1.4.pdf

336481 PerformanceSite_2_0-2.0.pdf

336481 RR_KeyPersonExpanded_2_0-2.0.pdf

336481 PHS398_ResearchPlan_4_0-4.0.pdf

336481 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

336481 RR_Budget_1_4-1.4.pdf

336481 RR_SubawardBudget30_1_4-1.4.pdf

336481 PHS398_ModularBudget_1_2-1.2.pdf

336481 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

336481 RR_SF424_5_0-5.0.pdf

336481 PHS398_CoverPageSupplement_5_0-5.0.pdf

336481 RR_OtherProjectInfo_1_4-1.4.pdf

336481 PerformanceSite_4_0-4.0.pdf

336481 RR_KeyPersonExpanded_4_0-4.0.pdf

336481 PHS398_ResearchPlan_5_0-5.0.pdf

336481 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

336481 RR_Budget_3_0-3.0.pdf

336481 RR_SubawardBudget30_3_0-3.0.pdf

336481 PHS398_ModularBudget_1_2-1.2.pdf

336481 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T05:43:10-05:00

Share This Post, Choose Your Platform!

About the Author: